Tonix Pharmaceuticals Holding Corporation News - TNXP

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Form 8-K - Current report

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Tonix received FDA’s Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

This Micro Cap Is Getting Bid Up Prior To Opening Bell

A New Jersey-based biotech company is finding quite a bit of success so far during Tuesday’s premarket hours after the company said that the...

Form 8-K - Current report

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

Tonix appoints two executives with decades of experience successfully launching and commercializing new CNS...

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

CHATHAM, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or...

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or...

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Value_Investor 2 hours ago

It is a key to break out 12/19/24's daily-high $0.72 or even 12/17/24's normal-session-high $1.3 since this Hidden Gem is currently on Hyper Oversold status!

This Diamond-In-Rough is also Super Undervalued now considering the NEW KEY drug TX-102's huge impacting to the world...

In fact, $1.94 was the premarket-session (before 9:30 AM) high on 12/17/24! However, after 9:30 AM in the regular-trading session (between 4:00 PM and 9:30 AM) the normal-session-high was only $1.3 which is $0.64 Less Than its daily REAL high $1.94!

Anyway, TNXP will easily bounce back to $1.94 again after we get rid of the remaining weak hands and flippers!

Hopefully the FDA's 74-day "Priority Review" letter will be issued as soon as tomorrow (12/31/2024) and as late as Thursday (01/02/2025)...

👍️ 1

Moonboy1 3 hours ago

I see this pumped to 42 today. I was out of day trades any way so didn't really matter. Let's see if it was just a dead cat bounce it not

👍️0

green maschine 3 hours ago

Yep, me too. Just posting here.

👍️0

insidernews 4 hours ago

Fibromyalgia market for 2023 is 2.7 billion

👍️ 1

koolmc 4 hours ago

they are playing other plays that are moving out there

👍️0

Dumb&dumber4long 6 hours ago

Any company looking into buying, better do it sooner than after FDA approval.
Unless it goes up to $11.7, I will be waiting on the review results

👍️ 1

green maschine 6 hours ago

If I had to guess, and I don't, but I will, I'd say .62 will be tomorrow.

👍️0

Dumb&dumber4long 6 hours ago

Will when it goes over 62

👍️ 1

green maschine 6 hours ago

Uh-oh, methinks too many peeps gave away their golden shares. tsk, tsk.

👍️0

green maschine 6 hours ago

Where is everybody. Time to celebrate the New Year a tad early!! 🪩🍹🥳

👍️0

034runner 6 hours ago

Another huge greenie

👍️0

green maschine 6 hours ago

Spoken just a wee bit too soon. Lol

👍️0

034runner 6 hours ago

Something's brewing. Not sure what it is. But its brewing with this type of action.

👍️0

green maschine 6 hours ago

Aha, and this one's up too. LFG TNXP 🚀

👍️0

034runner 6 hours ago

Wtf....big greenie

👍️0

Moonboy1 7 hours ago

This one is very disappointing. Seems like a slow bleed until reverse split? Isn't news due due of the form 74 letter any day?

👍️0

Moonboy1 8 hours ago

Haha. Well that one is up big now today so go figure. Never seen a stick anounce future offerings and then go up 40%.

👍️0

timberwolf7 9 hours ago

BIg Bio ETFS (really have no love for the ETFS cause of how they can jerk
individual stocks around) having a rough time lately. Another 'hit' on IBB, XBI today

Because they own so many (some reports say that because of how much money
they have to put to 'work', they effectively have to own at least some shares of all
of the bio tech stocks just to find enough to spread the money around),
what they do (up/down) they can distort what an individual stock should otherwise
be doing because of its own 'merits'.

👍️0

ttottip 9 hours ago

There will be a big bounce very soon.

👍️ 1 💯 1

green maschine 10 hours ago

You almost gave me a heart attack! Lets just talk about TNXP please.

👍️0

1jas 10 hours ago

you could have good news any time after the new years eve.

👍️0

Moonboy1 11 hours ago

WIM# just got hit with offerings. Can't win with these things.dillution

Moonboy1 15 hours ago

I've been messing with WIMI the past few days. Something went to be going on over there

👍️0

green maschine 20 hours ago

Here's another pumper's post for ya! 😎💰️

👍️0

G-ManSoFla 22 hours ago

A pumper posting another pumper's pump posts? Say that three times fast. By the time you say it will $TNXP be down another 10%?

👍️0

primecomm 1 day ago

Major Reversal Coming any day starting tomorrow $$$$$

👍️0

green maschine 1 day ago

💯🚀

👍️ 1

Stino2 2 days ago

Maybe because of shorters that this stock is going down!!

👍️0

G-ManSoFla 3 days ago

"Toxic" Garbage? This trash is losing 10% daily, day in-day out!!!!!

👍️0

Dumb&dumber4long 3 days ago

I could file it again under “whistle blower” category.
It may get more attention!

👍️0

Dumb&dumber4long 3 days ago

Useless or Corrupt!
I’d like to know which.
How about FINRA, policing short interest, should be reporting illegal activities to the SEC!

👍️0

timberwolf7 3 days ago

There was a video by an ex wall street firm employee recently over the abuse of ILLEGAL naked shorting

And he said, everyone KNOWS its happening, and they do it cause they can get away with it
cause the sec is useless in enforcing regulations..

👍️0

Dumb&dumber4long 3 days ago

It took about 30 minutes to file SEC complaint, just now.
It may or may not make a difference! Did it anyway.
Short volume, which includes dark pool on 12/16/2024 was over 916 million
shares, far exceeding outstanding shares of 186.89 millions (attached).
forcing the share price to fall from daily high of $1.3 ($1.94 in pre-market) to $0.32 today December 27th, 2024.
Ever wonder if it’s legal to short a stock by 5 times the outstanding shares?
No, it is not legal to short a stock by 5 times the outstanding shares. The U.S. Securities and Exchange Commission (SEC) has regulations in place to prevent excessive short selling that could manipulate the market. Specifically, naked short selling (shorting without borrowing the shares) and short sales that create or exacerbate downward price pressure are prohibited.
Additionally, institutional investment managers with significant short positions (exceeding $10 million or 2.5% of a company's total outstanding shares) must report their positions to the SEC. This helps maintain transparency and prevent market manipulation.

To report excessive short selling practices, you can file a complaint with the U.S. Securities and Exchange Commission (SEC). The SEC oversees and regulates short selling activities to prevent market manipulation and ensure market stability.
You can submit a complaint through the SEC's Office of the Whistleblower or use the SEC Complaint Center on their website. When filing a complaint, provide as much detail as possible about the suspected excessive short selling activity, including the stock involved, the parties engaged in the activity, and any evidence you may have.
https://fintel.io/ssv/us/tnxp

👍️0

timberwolf7 3 days ago

Whole market is puking this morn, not surprised given its the last week of the year approaching.

Only thing you can do if you own something is try to be sure the reason(s) WHY you took a position is
'intact', that you didn't over pay to 'participate' relative to a 'conservative' target price (vs a hyped up one),
and stay focused on whether or not it can still happen as time passes.

And the reason for using a conservative target price and not overpaying to participate? In the event 2025
gets ugly (and I expect it to once TRUMP takes over), a lot of 'overhyped' stocks may not get close to those
'expectations'. At least at the moment, TNXP looks like it can still justify $2.50-$3 IF approved..

Makes it pretty easy to sit back and watch the end of the year 'normal' activity take place..

PS: and if you still believe in a $2.50-$3 target price? Gather funds for an 'add' come 1 Jan.. when the
2024 tax loss selling period ends.

👍️0

Frankestin 3 days ago

So how much is the MC? Who knows what they are doing? I bet on $1, but it's a gamble with Seth! 🙏 Since we are at 7 RS and there are some stakes I added a little... now it's my money! I think it's just as risky for bulls as it is for bears! Could there be another RS imminent or not? The anomalous offer makes me think bad for the bears but I could be wrong! If it's a roast bear we'll see it go up for no reason like when they usually go down and you ask yourself why?

👍️0

Dumb&dumber4long 3 days ago

In case you missed a post on 12/20, short interest,
“Short Interest, think about it.
Short Interested reported 2x a month, on the 15th & end of month, be FINRA’s rules.
The 15th was before this huge volume (3.5 billions in 4 days, so far)
One thing for sure, short interest is up!
Hope it’s way up, to boost the next Big Short squeeze!
Don’t forget to check on short interest come January 2nd.

Short interest volume , to be updated (incl Dark Pool Volume) 314,697,968 shares
It was negligible a week ago!”
Check again next year, in a week
https://fintel.io/ssv/us/tnxp

👍️0

Moonboy1 4 days ago

Can't seem to catch a bottom

👍️0

Dumb&dumber4long 4 days ago

Do you even know a Death Cross if one were to stare you in the face!
Anyone looking at a day chart to call such a technical sign shows how illiterate one is.
Look at the 1Y/1D chart, see if you get it, I doubt it.
Look at the 6 month chart.
Well, heck look at the 3 month chart (although not to be used for any Cross sign).
Why don’t you cross to the other side.

👍️0

ATM123 4 days ago

3 Million plus or around 300 Million plus.....

👍️0

timberwolf7 4 days ago

G-man

you have anything of importance you intend to say?

or ya decided to be one of those board jack ---es

just curious (smile)

👍️ 1

G-ManSoFla 4 days ago

Death Cross on 12/23. Looks like yet another candidate for year-end tax loss harvesting!!! TRASH

👍️0

G-ManSoFla 4 days ago

Green what?

👍️0

G-ManSoFla 4 days ago

Oh really now?

👍️0

G-ManSoFla 4 days ago

biotech is trash

👍️0

green maschine 4 days ago

Huge reversal in the works here, over a dollar soon.

🤣 1

primecomm 4 days ago

No R/S.. Stop spreading false and misleading info. GLTA

👍️0

PirateLeviathan8 4 days ago

That will be 1 billion shares at the end of January.... Then they increase again from 250 million dollars to 500 million dollars in possible shares to be issued and then comes the reverse split to comply with the regulations and then comes the monster dilution and 1 month later the stock is penny stock again

👍️ 1 🤣 1

primecomm 4 days ago

$TNXP OS Shares: 3,138,804 as of 12-26 per V Stock Transfer Agent.

👍️ 1

Moonboy1 4 days ago

Trying to move back up it looks like?

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Tonix Pharmaceuticals Holding Corporation (TNXP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TNXP News

Form 8-K - Current report

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

This Micro Cap Is Getting Bid Up Prior To Opening Bell

Form 8-K - Current report

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

TNXP Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Tonix Pharmaceuticals Holding Corporation (TNXP) News

Tonix Pharmaceuticals Holding Corporation (TNXP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TNXP News

Form 8-K - Current report

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

This Micro Cap Is Getting Bid Up Prior To Opening Bell

Form 8-K - Current report

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

TNXP Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free